ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Relmada Therapeutics Inc

Relmada Therapeutics Inc (RLMD)

0.2855
-0.0095
(-3.22%)
Closed February 25 4:00PM
0.2896
0.0041
(1.44%)
After Hours: 7:58PM

Relmada Therapeutics Inc Financial Summary

The current RLMD market cap is 8.74M. The company's latest EPS is USD -3.2741 and P/E is -0.09.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -8.27M-60.84M-125.7M-161.25M-103.7M
Net Income -8.2M-59.46M-125.75M-157.04M-98.79M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 117.14M118.19M223.33M152.91M97.55M
Total Liabilities 1.46M12.6M15.06M12.47M12.2M
Total Equity 115.68M105.58M208.27M140.44M85.36M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -6.41M-27.81M-91.87M-103.8M-51.66M
Investing -80.17M-34.45M-54.12M19.73M50.45M
Financing 113.64M28.47M187.94M45.02M-98k
Market Cap 8.74M
Price to Earnings Ratio -0.09
Price to Sales Ratio 0
Price to Cash Ratio 2.06
Price to Book Ratio 0.1
Dividend Yield -

Share Statistics

Shares Outstanding 30.17M
Average Volume (1 week) 599.81k
Average Volume (1 Month) 2.13M
52 Week Change -94.92%
52 Week High 7.2225
52 Week Low 0.28
Spread (Intraday) 0.04 (11.86%)

Company Info

Company Name Relmada Therapeutics Inc
Address 50 west liberty street suite 880
reno, nevada 89501
Website https://www.relmada.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock